| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Operating activities: | |||||||||
Net loss | |||||||||
-39,477 | -36,287 | -31,770 | -15,636 | -27,138 | 7,133 | -24,437 | -4,282 | -18,296 | -8,564 |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||||
Share-based compensation | |||||||||
774 | 981 | 1,101 | 747 | 938 | 624 | 1,760 | 686 | 177 | 377 |
Stock issued for services | |||||||||
0 | 22 | 118 | 0 | - | - | - | - | - | - |
Stock issued in connection with consultant services | |||||||||
- | - | - | - | -204 | -645 | 0 | 0 | - | - |
Depreciation | |||||||||
4,434 | 4,580 | 4,622 | 4,670 | 4,730 | 4,681 | 4,636 | 3,042 | - | - |
Inventory provision | |||||||||
- | - | - | - | - | - | 0 | 105 | 201 | - |
Debt related fees and amortization expense | |||||||||
4,666 | 7,520 | 5,399 | 5,723 | 6,715 | 6,038 | 12,468 | 7,544 | - | - |
Depreciation | |||||||||
- | - | - | - | - | - | - | - | 1,141 | 760 |
Inventory provision | |||||||||
- | - | - | - | - | - | - | - | - | 283 |
Debt related fees and amortization expense | |||||||||
- | - | - | - | - | - | - | - | 4,624 | 1,343 |
Intangibles and other amortization expense | |||||||||
48 | 140 | 392 | 126 | 129 | 126 | 254 | 0 | - | - |
Accretion of Series A preferred units | |||||||||
2,257 | 44 | 0 | - | - | - | - | - | - | - |
Impairment loss on goodwill and intangible assets | |||||||||
- | - | - | - | 1,044 | 0 | - | - | - | - |
Loss/(gain) on extinguishment of debt | |||||||||
- | - | - | - | - | - | - | - | - | -14 |
Loss on sale/disposal of assets | |||||||||
- | - | - | - | - | - | - | - | - | 56 |
Gain on acquisition bargain purchase | |||||||||
- | - | - | - | - | - | 0 | 42,336 | - | - |
Deferred tax benefit | |||||||||
1,123 | 0 | - | - | - | - | 0 | -1,085 | - | - |
Change in fair value of warrant liability | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Gain on extinguishment of debt | |||||||||
- | - | - | 2,033 | -330 | -1,346 | -3,709 | -9,069 | -33 | - |
Loss on sale/disposal of assets | |||||||||
0 | -9 | 0 | -11 | 0 | -119 | 329 | 350 | - | - |
Loss on impairment of intangibles | |||||||||
0 | 865 | 0 | - | - | - | - | - | - | - |
Change in fair value of stock appreciation rights | |||||||||
-80 | -145 | 0 | -25 | -54 | 48 | -197 | 97 | - | - |
Gain on sale of assets | |||||||||
- | - | - | - | - | - | - | - | 401 | - |
Changes in operating assets and liabilities: | |||||||||
Gain on acquisition bargain purchase | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Deferred tax liability/(asset) | |||||||||
- | - | - | - | - | - | - | - | -98 | - |
Deferred tax liability | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Accounts receivable | |||||||||
963 | -1,079 | 1,015 | 403 | -72 | -1,498 | 1,487 | -3,114 | -1,316 | -78 |
Inventories | |||||||||
491 | 721 | 2,370 | -1,504 | 450 | 457 | -211 | 740 | -3,724 | -331 |
Prepaid expenses | |||||||||
-147 | -1,692 | -371 | 28 | -1,109 | 311 | -14 | -148 | -172 | -205 |
Other assets | |||||||||
594 | 380 | 425 | -890 | 979 | 187 | 694 | -476 | -1,476 | - |
Accounts payable | |||||||||
1,001 | 2,207 | 2,580 | -2,097 | 2,020 | -879 | -5,412 | 800 | 9,597 | - |
Accrued interest expense and fees | |||||||||
18,033 | 12,463 | 10,812 | 6,448 | 9,800 | 3,124 | 7,007 | 4,006 | 7,470 | - |
Other liabilities | |||||||||
7,088 | 425 | 1,497 | 474 | 744 | -2,956 | 814 | 2,775 | - | - |
Other current assets and other assets | |||||||||
- | - | - | - | - | - | - | - | - | -158 |
Accounts payable | |||||||||
- | - | - | - | - | - | - | - | - | 1,056 |
Accrued interest expense and fees, net of payments | |||||||||
- | - | - | - | - | - | - | - | - | 2,384 |
Other liabilities | |||||||||
- | - | - | - | - | - | - | - | - | -589 |
Other liabilities | |||||||||
- | - | - | - | - | - | - | - | 189 | - |
Net cash provided by (used in) operating activities | |||||||||
-2,034 | -5,506 | -8,688 | 371 | -786 | 20,592 | -1,683 | -16,931 | -1,246 | -3,682 |
Investing activities: | |||||||||
Capital expenditures | |||||||||
8,578 | 4,074 | 1,116 | 629 | 71 | 1,965 | 1,276 | 1,368 | 2,568 | 672 |
Proceeds from the sale of assets | |||||||||
- | - | - | - | - | - | 1,500 | 1,404 | 1,598 | - |
Acquisition of Cilion | |||||||||
- | - | - | - | - | - | 0 | 16,500 | 0 | - |
Cash obtained through merger | |||||||||
- | - | - | - | - | - | - | - | 1 | - |
Proceeds from land sale | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Cash obtained through merger | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash used in investing activities | |||||||||
-8,578 | -4,074 | -1,116 | -629 | -71 | -1,965 | 224 | -16,464 | -967 | -672 |
Financing activities: | |||||||||
Proceeds from borrowings | |||||||||
- | - | - | - | 30,331 | 9,884 | 10,541 | 47,165 | - | 4,500 |
Repayments of borrowings | |||||||||
- | - | - | - | 29,293 | 32,688 | 5,374 | 13,830 | - | 850 |
Proceeds from borrowings | |||||||||
54,834 | 20,071 | 14,798 | 20,583 | - | - | - | - | - | - |
Repayments of borrowings | |||||||||
51,714 | 18,010 | 10,037 | - | - | - | - | - | - | - |
Proceeds from borrowings | |||||||||
1,480 | 3,144 | 3,614 | - | - | - | - | - | - | - |
Repayments of borrowings | |||||||||
164 | 1,775 | 0 | 18,956 | - | - | - | - | - | - |
GAFI renewal fee payment | |||||||||
-530 | 0 | - | - | - | - | - | - | - | - |
GAFI proceeds from borrowings | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Proceeds from borrowing under secured debt facilities | |||||||||
- | - | - | - | - | - | - | - | 3,621 | - |
Repayments of borrowing under secured debt facilities | |||||||||
- | - | - | - | - | - | - | - | 3,053 | - |
Proceeds from borrowings under related party credit arrangements | |||||||||
- | - | - | - | - | - | - | - | - | 2,612 |
Payments of borrowing under related party credit arrangements | |||||||||
- | - | - | - | - | - | - | - | - | 1,600 |
Proceeds from borrowings under unsecured short term notes and working capital lines of credit | |||||||||
- | - | - | - | - | - | - | - | 8,773 | 4,457 |
Repayments of borrowings under unsecured and subdebt notes and working capital facility | |||||||||
- | - | - | - | - | - | - | - | 7,476 | 4,260 |
Issuance of common stock for services, option and warrant exercises | |||||||||
- | - | - | - | 23 | 5 | 1,083 | 1 | 0 | - |
Payment of debt guarantee fee | |||||||||
- | - | - | - | 245 | 172 | 0 | 0 | - | - |
GAFI renewal fee payment | |||||||||
- | - | - | - | - | 255 | 0 | 0 | - | - |
Grant proceeds received for capital expenditures | |||||||||
1,364 | 0 | - | - | - | - | - | - | - | - |
Proceeds from Series A preferred units financing | |||||||||
4,815 | 6,961 | 0 | - | - | - | - | - | - | - |
Net cash provided by financing activities | |||||||||
10,085 | 10,391 | 8,375 | 1,627 | 816 | -23,226 | 6,250 | 33,336 | 1,865 | 4,859 |
Effect of exchange rate changes on cash and cash equivalents | |||||||||
-5 | -51 | 371 | -166 | -8 | 5 | -156 | 101 | -84 | 126 |
Net cash and cash equivalents for period | |||||||||
-532 | 760 | -1,058 | 1,203 | -49 | -4,594 | 4,635 | 42 | -433 | 630 |
Supplemental disclosures of cash flow information, cash paid: | |||||||||
Cash paid for interest, net of capitalized interest of $88 and $64 for the three months ended March 31, 2020 and 2019, respectively | |||||||||
2,476 | 5,590 | 3,092 | 4,894 | 478 | 6,824 | 4,522 | 2,085 | - | - |
Interest paid | |||||||||
- | - | - | - | - | - | - | - | 1,021 | 151 |
Income taxes paid | |||||||||
8 | 6 | 6 | 6 | 6 | 6 | 6 | 4 | 3 | 3 |
Supplemental disclosures of cash flow information, non-cash transactions: | |||||||||
Subordinated debt extension fees added to debt | |||||||||
680 | 680 | 680 | 680 | - | - | - | - | - | - |
Proceeds from exercise of stock options applied to accounts payable | |||||||||
- | - | - | - | 21 | 16 | 0 | 0 | - | - |
Stock issued to pay interest and fees on borrowings | |||||||||
- | - | - | - | - | - | - | - | 1,662 | 202 |
Fair value of warrants issued to subordinated debt holders | |||||||||
162 | 235 | 321 | 579 | 1,087 | 1,301 | 1,127 | 0 | 1,452 | - |
Repurchase of common stock added to TEC promissory note | |||||||||
- | - | 451 | 0 | - | - | - | - | - | - |
TEC debt extension, waiver fees, promissory notes fees added to debt | |||||||||
1,602 | 4,255 | 5,615 | - | - | - | - | - | - | - |
Capital expenditures in accounts payable | |||||||||
2,391 | 905 | - | - | - | - | - | - | - | - |
Operating lease liabilities arising from obtaining right of use assets | |||||||||
1,181 | 0 | - | - | - | - | - | - | - | - |
Exercise of stock appreciation rights added to GAFI debt | |||||||||
1,050 | 0 | - | - | - | - | - | - | - | - |
GAFI plant, property & equipment acquired with debt | |||||||||
- | - | 15,431 | 0 | - | - | - | - | - | - |
Payment of TEC bridge loan added to GAFI Revolving loan | |||||||||
- | - | 3,669 | 0 | - | - | - | - | - | - |
Debt exchanged for prepaid interest on GAFI Term loan | |||||||||
0 | 200 | 2,250 | 0 | - | - | - | - | - | - |
GAFI Amendment No. 1 & 2 fees added to debt | |||||||||
0 | 250 | 0 | - | - | - | - | - | - | - |
Stock Appreciation Rights issued for GAFI Amendment No. 1 | |||||||||
0 | 1,277 | 0 | - | - | - | - | - | - | - |
Capital expenditures not paid yet | |||||||||
- | - | 0 | - | - | - | - | - | - | - |
Stock issued for interest on debt | |||||||||
- | - | - | - | - | 0 | - | - | - | - |
Repurchase of common stock on revolver loan advance | |||||||||
- | - | - | - | 7,479 | 0 | - | - | - | - |
Transfer between debt and other liabilities | |||||||||
- | - | - | - | - | 438 | 0 | 0 | - | - |
Stock issued in connection with services and interest on debt | |||||||||
- | - | - | - | 432 | - | 0 | 0 | - | - |
Senior debt extension and waiver fees added to debt | |||||||||
- | - | - | 4,940 | - | - | - | - | - | - |
TEC promissory note fees and fees for Goodland transaction | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Payments of principal, fees and interest paid in stock | |||||||||
- | - | - | - | - | - | 3,616 | 11,886 | - | - |
Issuance of shares to related party for repayment of line of credit | |||||||||
- | - | - | - | - | - | 822 | 4,107 | - | - |
Issuance of warrants to non-employees to secure procurement and working capital | |||||||||
- | - | - | - | - | - | 336 | 0 | - | - |
Other asset transferred to related party | |||||||||
- | - | - | - | - | - | 170 | 0 | - | - |
Warrant liability transferred to equity upon exercise | |||||||||
- | - | - | - | - | - | 1,007 | 0 | - | - |
Exercise of conversion feature on note to equity | |||||||||
- | - | - | - | - | 47 | 0 | 0 | - | - |
Issuance of shares for acquisition | |||||||||
- | - | - | - | - | - | 0 | 12,511 | 1,890 | 0 |
Beneficial conversion discount on related party debt | |||||||||
- | - | - | - | - | - | 0 | 885 | - | - |
Seller note payable at fair value | |||||||||
- | - | - | - | - | - | 0 | 3,584 | - | - |
Settlement of accounts payable through transfer of equipment | |||||||||
- | - | - | 66 | 0 | 99 | 0 | 0 | - | - |
Settlement of subordinated debt through issuing stock | |||||||||
- | - | 132 | 0 | - | - | - | - | - | - |
Beneficial conversion discount on related party debt | |||||||||
- | - | - | - | - | - | - | - | 1,732 | - |
Seller note payable issued in Cilion acquisition | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Payment of loans and fees by issuance of stock to related party | |||||||||
- | - | - | - | - | - | - | - | - | 162 |
Beneficial conversion discount on related party | |||||||||
- | - | - | - | - | - | - | - | - | 1,556 |
Property, plant & equipment purchases included in accounts payable | |||||||||
- | - | - | - | - | - | - | - | - | 466 |